Stay updated on Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial

Sign up to get notified when there's something new on the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page reorganizes site data into a single 'Locations' section listing participating states, replacing the prior per-state subsections, and updates the revision to v3.3.3.
    Difference
    0.8%
    Check dated 2025-12-23T09:43:16.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    The Publications section description was updated to indicate PubMed as the data source and that publications may not all pertain to the study; the revision note shows an update from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:56:25.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The top-level notice about government funding and NIH operating status has been removed. The page still presents the study details, eligibility criteria, and locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T20:14:40.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Non-significant changes observed: the page retains the same study details with only minor formatting/UI adjustments and no new or removed critical information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T14:24:38.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Add: new operating-status notice and v3.2.0 release; Remove: previously listed resource topic (B-cell chronic lymphocytic leukemia) and v3.1.0 reference. The page now highlights current operating status and updated version, while some resource entries were trimmed.
    Difference
    3%
    Check dated 2025-10-06T04:28:54.000Z thumbnail image
  9. Check
    104 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T01:14:09.000Z thumbnail image

Stay in the know with updates to Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Duvelisib vs Ofatumumab in CLL/SLL Clinical Trial page.